11:29 AM EST, 12/09/2024 (MT Newswires) -- NetraMark Holdings ( AINMF ) was last seen up 20% after the medical-AI company on Monday said it entered into a pilot collaboration agreement with a top five pharmaceutical company.

The company said the pilot is seeking to unlock novel insights and hypotheses regarding patient populations to facilitate the development of new therapeutics for autoimmune disorders. NetraMark ( AINMF ) added it will complete a comprehensive review of the provided data as part of this collaboration.

The company said the partnership seeks to uncover actionable insights that drive innovation in treatment strategies and patient care and provide a path to possible co-publishing opportunities and for the pharmaceutical company to enhance future clinical trials.

Shares of the company were last seen up by $0.21 at $1.26 on the Canadian Securities Exchange, a 52-week high.

Price: 1.26, Change: +0.21, Percent Change: +20.00